XBIT
XBiotech Inc.
$2.75
+$0.03(+1.10%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$82.93M
Volume
170.04K
52W Range
$2.50 - $8.32
Target Price
$18.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | -- | -- | -- | -- | $44.0M | $18.4M | $4.0M | -- | -- | ||
| Total Revenue | -- | -- | -- | -- | -- | $44.0M | $18.4M | $4.0M | -- | -- | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | -- | -- | -- | $34.5M | $5.8M | $651.0K | -- | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | -- | -- | -- | -- | $9.4M | $12.6M | $3.4M | -- | -- | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-37.5M | $-52.8M | $-34.1M | $-21.0M | $31.2M | $27.7M | $37.7M | $37.8M | $37.5M | $42.5M | ||
| Research & Development | $31.3M | $42.5M | $26.4M | $15.7M | $24.1M | $9.5M | $28.3M | $31.5M | $32.8M | $37.8M | ||
| Research Expense | $31.3M | $42.5M | $26.4M | $15.7M | $24.1M | $9.5M | $28.3M | $31.5M | $32.8M | $37.8M | ||
| Selling, General & Administrative | $6.2M | $10.3M | $7.6M | $5.3M | $7.1M | $18.2M | $9.4M | $6.3M | $4.7M | $4.7M | ||
| General & Administrative Expenses | $6.2M | $10.3M | $7.6M | $5.3M | $7.1M | $18.2M | $9.4M | $6.3M | $4.7M | $4.7M | ||
| Salaries & Wages | $-4.4M | $-5.6M | $-2.5M | $-1.7M | -- | -- | -- | -- | $3.3M | $1.8M | ||
| Depreciation & Amortization | $-699.0K | $-698.0K | $-1.5M | $-2.4M | $2.4M | $2.2M | $2.6M | $2.6M | $1.7M | $1.7M | ||
| Depreciation & Amortization | $-699.0K | $-698.0K | $-1.5M | $-2.4M | $2.4M | $2.2M | $2.6M | $2.6M | $1.7M | $1.7M | ||
| Other Operating Expenses | -- | -- | -- | -- | $-46.0K | $-49.0K | $-42.0K | $-130.0K | $-389.0K | $-660.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-37.5M | $-52.8M | $-34.1M | $-21.0M | $-31.2M | $-18.3M | $-25.1M | $-34.5M | $-37.5M | $-42.5M | ||
| EBITDA | $-36.8M | $-52.1M | $-31.7M | $-18.7M | $720.8M | $-16.0M | $-22.4M | $-31.9M | $-22.6M | $-36.8M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Intinc | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-807.0K | ||
| Net Non-Operating Interest Income/Expense | -- | $49.0K | $354.0K | $400.0K | -- | -- | -- | $-3.8M | $-10.4M | $-807.0K | ||
| Gain on Sale of Securities | -- | -- | -- | -- | $564.0K | $2.5M | $467.0K | $3.8M | $10.4M | $9.8M | ||
| Other Income/Expense | $-21.0K | -- | -- | $-4.0K | $-574.0K | $-2.0M | $-335.0K | $-2.9M | $-11.3M | $-10.2M | ||
| Other Special Charges | $21.0K | -- | -- | $4.0K | $10.0K | $-503.0K | $-132.0K | $-121.0K | $883.0K | $432.0K | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-37.5M | $-52.8M | $-33.1M | $-21.1M | $718.5M | $-18.3M | $-25.1M | $-34.5M | $-24.3M | $-38.6M | ||
| Pre-Tax Income | $-37.5M | $-52.8M | $-33.1M | $-21.1M | $718.5M | $-12.8M | $-25.5M | $-33.6M | $-24.3M | $-38.6M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | -- | -- | $-4.5M | -- | $49.8M | $-1.6M | $-8.0M | $-688.0K | $244.0K | $-32.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-37.5M | $-52.8M | $-33.1M | $-21.1M | $668.6M | $-11.2M | $-17.4M | $-32.9M | $-24.6M | $-38.5M | ||
| Net Income (Continuing Operations) | $-37.5M | $-52.8M | $-33.1M | $-21.1M | $668.6M | $-11.2M | $-17.4M | $-32.9M | $-24.6M | $-38.5M | ||
| Net Income (Discontinued Operations) | $-37.5M | $-52.8M | $-33.1M | $-21.1M | $668.6M | $-11.2M | $-17.4M | $-32.9M | $-24.6M | $-38.5M | ||
| Net Income (Common Stockholders) | $-37.5M | $-52.8M | $-33.1M | $-21.1M | $668.6M | $-11.2M | $-17.4M | $-32.9M | $-24.6M | $-38.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-33.5M | -- | -- | $-38.6M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-37.5M | $-52.8M | $-34.1M | $-21.0M | $31.2M | $62.3M | $43.5M | $38.5M | $37.5M | $42.5M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $30.8M | $32.4M | $34.9M | $35.8M | $38.9M | $30.8M | $30.0M | $30.4M | $30.4M | $30.5M | ||
| Average Shares Outstanding (Diluted) | $30.7M | $32.4M | $34.9M | $35.8M | $46.3M | $30.8M | $30.0M | $30.4M | $30.4M | $30.5M | ||
| Shares Outstanding | $32.3M | $35.1M | $35.4M | $36.0M | $28.9M | $29.5M | $30.4M | $30.4M | $30.5M | $30.5M | ||
| Basic EPS | -- | -- | -- | $-0.59 | $17.17 | $-0.36 | $-0.58 | $-1.08 | $-0.81 | $-1.26 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $17.17 | $-0.36 | $-0.58 | $-1.08 | $-0.81 | $-1.26 | ||
| Diluted EPS | $-1.22 | $-1.63 | $-0.95 | $-0.59 | $14.44 | $-0.36 | $-0.58 | $-1.08 | $-0.81 | $-1.26 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $14.44 | $-0.36 | $-0.58 | $-1.08 | $-0.81 | $-1.26 | ||
| OTHER METRICS | ||||||||||||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | -- | $750.0M | -- | -- | -- | -- | -- | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | $750.0M | -- | -- | -- | -- | -- | ||
| Other Gand A | $6.2M | $10.3M | $7.6M | $5.3M | $7.1M | $18.2M | $9.4M | $6.3M | $4.7M | $4.7M | ||
| Rent And Landing Fees | $6.2M | $10.3M | $7.6M | $5.3M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XBIT | $2.75 | +1.1% | 170.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |